I remember reading about that when molnupiravir was introduced. It was clear this could happen but having an effective drug in this case is more important. Now

I remember reading about that when molnupiravir was introduced. It was clear this could happen but having an effective drug in this case is more important. Now what bothers me when I read the article Merck likes to downplay any risks - and as far as I understood Pfizer created Paxlovid which is safer as far as I remember.